We are live on ! Find out more
GCTK icon

GlucoTrack

10 hedge funds and large institutions have $40.1K invested in GlucoTrack in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 0 increasing their positions, reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding

Funds holding: 410 (+6)

150% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 4

0.04% less ownership

Funds ownership: 0.06%0.02% (-0.04%)

43% less capital invested

Capital invested by funds: $69.8K → $40.1K (-$29.7K)

Holders
10
Holders Change
+6
Holders Change %
+150%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change

GCTK Hedge Fund Activity: Q2 2025 in Review

10 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q2 2025, worth a combined $40.1K — down 43% from $69.8K a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new GCTK positions and 4 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Bank of America, opening a new position worth an estimated $35.9K. The largest seller was Alerus Financial, exiting entirely with an estimated $52.4K sold.

  • 10 institutional investors held GlucoTrack (GCTK) as of Q2 2025, up from 4 in Q1 2025.
  • Funds reported $40.1K of GlucoTrack stock for Q2 2025, down 43% quarter-over-quarter.
  • 10 funds opened new GlucoTrack positions in Q2 2025 and 4 closed out, a net change of +6 holders.
  • The largest GlucoTrack buyer in Q2 2025 was Bank of America, an estimated $35.9K added.
  • The largest GlucoTrack seller in Q2 2025 was Alerus Financial, an estimated $52.4K sold.

Based on aggregated 13F filings for Q2 2025.